Acutaas Chemicals share news, announcements and annual reports
NSE: ACUTAASBSE: 543349Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹3,348.80.
27 Oct: open ₹3,365.00, high ₹3,900.00, low ₹3,360.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹31,056 Cr347th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 70.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 16.72
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.07%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 26.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 47,46,62021.2% delivered
Acutaas Chemicals has 421 announcements on record, routine notices left out; 5 in the 30 days to 28 Oct 2026, the latest on 27 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Acutaas Chemicals quarterly results
The board met on 27 Oct 2026 to consider financial results
Notice filed 22 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Acutaas Chemicals annual reports, presentations and earnings calls
The company's own documents, latest first.Acutaas Chemicals financials, year by year
Annual reports5
- Annual report, year to Mar 202629 Aug 2026
- Annual report, year to Mar 20251 Sep 2025
- Annual report, year to Mar 202429 Aug 2024
- Annual report, year to Mar 20232 Sep 2023, a zip file
- Annual report, year to Mar 202218 Jul 2022, a zip file
Investor presentations24
- Investor Presentation27 Oct 2026
- Investor Presentation24 Jul 2026
- Investor Presentation16 May 2026
- Investor Presentation30 Apr 2026
- Investor Presentation28 Jan 2026
19 earlier presentations
- Investor Presentation17 Oct 2025
- Investor Presentation30 Jul 2025
- Investor Presentation2 May 2025
- Investor Presentation28 Jan 2025
- Investor Presentation29 Oct 2024
- Investor Presentation12 Aug 2024
- Investor Presentation16 May 2024
- Investor Presentation11 May 2024
- Investor Presentation12 Feb 2024
- Investor Presentation9 Nov 2023
- Investor Presentation11 Aug 2023
- Investor Presentation14 May 2023
- Investor Presentation4 Feb 2023
- Investor Presentation5 Nov 2022
- Revised Investor Presentation for financial results Q1 FY23 and other business matters.10 Aug 2022
- Investor Presentation for the financial results Q1 FY 2310 Aug 2022
- Investor Presentation16 May 2022
- Investor Presentation8 Feb 2022
- Investor Presentation25 Oct 2021
Earnings calls39
- Link of Recording27 Oct 2026
- Transcript28 Jul 2026
- Link of Recording24 Jul 2026
- Transcript6 May 2026
- Link of Recording30 Apr 2026
34 earlier call documents
- Transcript3 Feb 2026
- Link of Recording28 Jan 2026
- Transcript24 Oct 2025
- Link of Recording17 Oct 2025
- Transcript5 Aug 2025
- Link of Recording30 Jul 2025
- Transcript8 May 2025
- Link of Recording2 May 2025
- Transcript1 Feb 2025
- Link of Recording29 Jan 2025
- Transcript5 Nov 2024
- Link of Recording29 Oct 2024
- Transcript16 Aug 2024
- Link of Recording12 Aug 2024
- Transcript17 May 2024
- Link of Recording13 May 2024
- Transcript16 Feb 2024
- Link of Recording12 Feb 2024
- Transcript16 Nov 2023
- Link of Recording9 Nov 2023
- Transcript21 Aug 2023
- Transcript19 May 2023
- Link of Recording15 May 2023
- Earnings Call Transcript10 Feb 2023
- Link of Recording4 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call held on November 5, 202212 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call held on November 5, 2022.6 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call17 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call16 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call10 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call24 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call18 May 2022
- Transcript14 Feb 2022
- Earnings Transcript held on October 25, 202130 Oct 2021
Acutaas Chemicals share news and announcements
Newest first. Page 1 of 9.
Oct 2026
27 Oct · Business
27 Oct · Results
22 Oct · Analysts
22 Oct · Board meeting
17 Oct · Business
Sep 2026
26 Sep · Management
24 Sep · Business
24 Sep · Meeting
22 Sep · Analysts
10 Sep
4 Sep
Aug 2026
29 Aug
29 Aug · Corporate action
22 Aug
18 Aug
8 Aug · Analysts
Jul 2026
24 Jul · Business
24 Jul · Results
20 Jul · Analysts
20 Jul · Board meeting
2 Jul · Management
Jun 2026
23 Jun · Legal
22 Jun · Legal
May 2026
18 May · Management
14 May · Analysts
Apr 2026
30 Apr · General Updates
30 Apr · Business
30 Apr · Results
27 Apr · Analysts
Mar 2026
2 Mar · Analysts
Feb 2026
17 Feb · Analysts
11 Feb · General Updates
Jan 2026
30 Jan · Analysts
29 Jan · Updates
28 Jan · Business
28 Jan · Results
27 Jan
22 Jan · Analysts
21 Jan · Board meeting
19 Jan · General Updates
Dec 2025
22 Dec · Disclosure
4 Dec · Rating
Nov 2025
11 Nov · Analysts
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 27 Oct 2026Resultsup 13.27%+12.7 pts vs Nifty 500market median −0.7% · volume 12.2× usual · delivery −27.7 pts against usual · The announcement
- 28 Sep 2026Board or managers changeddown 1.78%−0.1 pts vs Nifty 500market median 0.0% · five sessions −4.6% (−1.8 pts vs Nifty 500) · volume 0.6× usual · delivery −1.2 pts against usual · The announcement
- 24 Jul 2026Resultsdown 5.77%−5.5 pts vs Nifty 500market median −0.7% · five sessions −6.5% (−8.1 pts vs Nifty 500) · volume 3.1× usual · delivery −15.7 pts against usual · The announcement
- 3 Jul 2026Board or managers changedup 0.08%−0.1 pts vs Nifty 500market median 0.0% · five sessions −6.3% (−5.5 pts vs Nifty 500) · volume 0.6× usual · delivery +0.6 pts against usual · The announcement
- 19 May 2026Board or managers changedup 3.12%+2.9 pts vs Nifty 500market median 0.0% · five sessions +4.5% (+2.4 pts vs Nifty 500) · volume 1.1× usual · delivery −5.4 pts against usual · The announcement
- 30 Apr 2026Resultsup 3.66%+4.5 pts vs Nifty 500market median −0.7% · five sessions +8.9% (+7.4 pts vs Nifty 500) · volume 5.1× usual · delivery −19.6 pts against usual · The announcement
- 28 Jan 2026Resultsup 7.78%+6.6 pts vs Nifty 500market median −0.7% · five sessions +12.1% (+12.0 pts vs Nifty 500) · volume 4.2× usual · delivery −17.4 pts against usual · The announcement
- 5 Dec 2025Credit ratingdown 0.09%−0.5 pts vs Nifty 500market median 0.0% · five sessions −2.9% (−2.1 pts vs Nifty 500) · volume 0.3× usual · delivery +0.1 pts against usual · The announcement
- 17 Oct 2025Resultsup 6.02%+5.9 pts vs Nifty 500market median −0.7% · five sessions +8.4% (+7.8 pts vs Nifty 500) · volume 7.1× usual · delivery −24.6 pts against usual · The announcement
- 30 Jul 2025Resultsup 4.56%+4.4 pts vs Nifty 500market median −0.7% · five sessions +15.0% (+15.9 pts vs Nifty 500) · volume 3.9× usual · delivery −18.1 pts against usual · The announcement
13 earlier announcements
- 12 May 2025Board or managers changedup 1.97%−1.9 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−8.7 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 2 May 2025Resultsup 2.76%+2.9 pts vs Nifty 500market median −0.7% · five sessions +2.8% (+3.7 pts vs Nifty 500) · volume 9.8× usual · The announcement
- 18 Dec 2024Credit ratingup 1.91%+2.6 pts vs Nifty 500market median 0.0% · five sessions +12.1% (+15.1 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 4 Oct 2024Board or managers changedup 1.66%+2.6 pts vs Nifty 500market median 0.0% · five sessions +3.1% (+3.8 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 13 Aug 2024Board or managers changeddown 3.79%−2.9 pts vs Nifty 500market median 0.0% · five sessions +1.1% (−0.5 pts vs Nifty 500) · volume 3.0× usual · The announcement
- 13 May 2024Dividendup 2.00%+1.8 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+0.7 pts vs Nifty 500) · volume 3.9× usual · The announcement
- 2 May 2024Dividenddown 1.27%−1.7 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−0.9 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 23 Nov 2023Credit ratingdown 0.42%−0.5 pts vs Nifty 500market median 0.0% · five sessions +1.5% (−0.6 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 15 May 2023Dividendup 7.21%+6.7 pts vs Nifty 500market median 0.0% · five sessions +9.6% (+10.0 pts vs Nifty 500) · volume 10.5× usual · The announcement
- 6 Feb 2023Resultsup 2.50%+2.7 pts vs Nifty 500market median −0.7% · five sessions +3.9% (+3.5 pts vs Nifty 500) · volume 2.3× usual · The announcement
- 7 Nov 2022Resultsdown 2.16%−2.7 pts vs Nifty 500market median −0.7% · five sessions −10.2% (−11.0 pts vs Nifty 500) · volume 2.0× usual · The announcement
- 10 Aug 2022Resultsdown 3.40%−3.3 pts vs Nifty 500market median −0.7% · five sessions −4.8% (−7.4 pts vs Nifty 500) · volume 2.6× usual · The announcement
- 16 May 2022Dividendup 4.62%+3.9 pts vs Nifty 500market median 0.0% · five sessions +2.2% (−1.0 pts vs Nifty 500) · volume 1.6× usual · The announcement
Acutaas Chemicals results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Revenue from operations | Quarter to Jun 2023 | Consolidated | 142.35 | 153.72 | +8.0% | 11 Aug 2023 | 13 Nov 2023 |
| Other income | Quarter to Jun 2023 | Consolidated | 1.10 | 1.15 | +4.6% | 11 Aug 2023 | 13 Nov 2023 |
| Total income | Quarter to Jun 2023 | Consolidated | 143.45 | 154.87 | +8.0% | 11 Aug 2023 | 13 Nov 2023 |
| Materials used | Quarter to Jun 2023 | Consolidated | 70.26 | 71.71 | +2.1% | 11 Aug 2023 | 13 Nov 2023 |
| Employee costs | Quarter to Jun 2023 | Consolidated | 13.69 | 14.14 | +3.3% | 11 Aug 2023 | 13 Nov 2023 |
| Depreciation and amortisation | Quarter to Jun 2023 | Consolidated | 3.42 | 3.71 | +8.4% | 11 Aug 2023 | 13 Nov 2023 |
| Other expenses | Quarter to Jun 2023 | Consolidated | 24.89 | 25.50 | +2.4% | 11 Aug 2023 | 13 Nov 2023 |
| Total expenses | Quarter to Jun 2023 | Consolidated | 121.13 | 123.93 | +2.3% | 11 Aug 2023 | 13 Nov 2023 |
| Profit before tax | Quarter to Jun 2023 | Consolidated | 22.32 | 30.94 | +38.6% | 11 Aug 2023 | 13 Nov 2023 |
| Tax | Quarter to Jun 2023 | Consolidated | 5.67 | 8.70 | +53.5% | 11 Aug 2023 | 13 Nov 2023 |